Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[Q]: The FDA said it received 85 reports from patients who switched from Wellbutrin XL to Teva Pharmaceutical Industries Ltd and Impax Laboratories Inc’s cheaper generic, including 78 who said they slipped back into depression. Other patients reported new or worsening side effects, including headaches, fatigue, anxiety and digestion issues. “The question is whether the reported lack of efficacy and/or new onset side effects in these patients who switched suggest a problem with the generic product ... or have some other explanation,” the FDA said in a statement on its website. Agency scientists reviewed 300-milligram versions of the two drugs, which both use once-a-day formulations of the chemical bupropion, and found the data did not show that the problems stemmed from any differences between the two drugs. One factor that could account for the reported problems is the natural recurrence of depression, which can happen despite treatment, the FDA said. Half of the patients who went back on the name-brand drug said they improved, the agency said, adding that it would continue to monitor the issue. FDA officials received the reports during the first half of 2007. Teva and Impax’s version of Wellbutrin was approved in 2006. Watson Pharmaceuticals Inc also makes a 300-mg XL version of bupropion, though it was not part of the FDA’s review. GlaxoSmithKline makes other versions of Wellbutrin that face generic competition. Total sales of Wellbutrin slipped 37 percent last year in the face of generic competition, the company has reported. The drugmaker could not comment on the FDA’s conclusion because it did not have access to the data used but is pleased the agency would continue its monitoring, GlaxoSmithKline spokeswoman Mary Anne Rhyne said. Teva spokeswoman Denise Bradley said the company would issue a statement later. Shares of GlaxoSmithKline rose 39 cents to $42.47 on the New York Stock Exchange. Teva rose 65 cents, or 1.4 percent, to $46.67 on Nasdaq.
[A]: FDA says generic Wellbutrin OK despite reports.


[Q]: Thirteen years ago, the Advisory Committee on Immunization Practices recommended hepatitis A shots for all U.S. children at age 1. On Thursday, the panel said the shots should be given to older children who weren’t vaccinated earlier, including 14- to 18-year-olds who turned 1 before the recommendation was made. The panel also recommended the shots for every person with HIV. About 1.1 million Americans are estimated to have HIV, the virus that causes AIDS. People with HIV tend to develop more severe hepatitis A illnesses. U.S. hepatitis A infections and deaths have risen in the last two years, spurred by outbreaks among the homeless and drug users.
[A]: Health panel: Millions of US kids should get hepatitis shot.


[Q]: The Richmond Times-Dispatch reported that of the more than 1,800 cases confirmed by lab reports since the start of the 2019-2020 flu season, 75% have been identified as type B, according to the Virginia Department of Health. That trend is in line with national statistics. Scott Pauley, a spokesman for the Centers for Disease Control and Prevention, told the newspaper it’s the first time since the 1992-1993 flu season that influenza B has been identified more often than influenza A nationally. Pauley said that could mean a less severe season in terms of deaths, but still a strong one. The CDC, which recommends that everyone 6 months and older receive a flu vaccine, said  it does not yet have vaccine effectiveness estimates for this season. So far there have been 255 reported pneumonia- and influenza-associated deaths reported by the Virginia Health Department this flu season, the newspaper reported. There have not been any reported pediatric deaths.
[A]:
Less common flu strain prominent this year in Virginia.